CA2322134C - Improved stent cell configurations - Google Patents
Improved stent cell configurations Download PDFInfo
- Publication number
- CA2322134C CA2322134C CA002322134A CA2322134A CA2322134C CA 2322134 C CA2322134 C CA 2322134C CA 002322134 A CA002322134 A CA 002322134A CA 2322134 A CA2322134 A CA 2322134A CA 2322134 C CA2322134 C CA 2322134C
- Authority
- CA
- Canada
- Prior art keywords
- stent
- structures
- multibonate
- cell
- tribonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91516—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
Abstract
A generally cylindrical, radially expandable stent may be composed of a plurality of interconnected multibonate cell structures. The cells have three or more enlarged end portions radiating from a common cente r within the cell. The cells may be of tribonate or higher order multibonate configuration. Stents composed up of a series of generally multibonate cell elements are also disclosed.
Description
IMPROVED STENT CELL CONFIGURATIONS
Field of the Invention This invention relates to stents of improved cell configuration.
Brief Description of the Prior Art Stents are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. They have also been implanted in urinary tracts and bile ducts. They are used to reinforce body vessels and to prevent restenosis following angioplasty in the vascular system. They may be self-expanding or expanded by an internal radial force, such as when mounted on a balloon.
In the past, stents have been generally tubular but have been composed of many cell configurations and have been made of many materials, including metals and plastic. Ordinary metals such as stainless steel have been used as have shape memory metals such as Nitinol and the like. Stents have also been made of biodegradable plastic materials. Such stents have been formed from wire, tube stock, and the like.
Summary of the Invention This invention provides new configurations of the cells making up stents which may be adapted to all of the various types of prior art stents described above and/or known previously in the art. In general, as will be seen from the embodiments described hereinafter, the improved cell configurations are generally trichotomous, i. e., divided into three parts. More particularly, the cells are of a triskelion-like or trifurcate configuration, i.e., composed of three parts with axes of each part radiating from a common center. There are numerous advantages to the new configurations. For example, the configurations of the invention limit recoil and add resistance to
Field of the Invention This invention relates to stents of improved cell configuration.
Brief Description of the Prior Art Stents are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. They have also been implanted in urinary tracts and bile ducts. They are used to reinforce body vessels and to prevent restenosis following angioplasty in the vascular system. They may be self-expanding or expanded by an internal radial force, such as when mounted on a balloon.
In the past, stents have been generally tubular but have been composed of many cell configurations and have been made of many materials, including metals and plastic. Ordinary metals such as stainless steel have been used as have shape memory metals such as Nitinol and the like. Stents have also been made of biodegradable plastic materials. Such stents have been formed from wire, tube stock, and the like.
Summary of the Invention This invention provides new configurations of the cells making up stents which may be adapted to all of the various types of prior art stents described above and/or known previously in the art. In general, as will be seen from the embodiments described hereinafter, the improved cell configurations are generally trichotomous, i. e., divided into three parts. More particularly, the cells are of a triskelion-like or trifurcate configuration, i.e., composed of three parts with axes of each part radiating from a common center. There are numerous advantages to the new configurations. For example, the configurations of the invention limit recoil and add resistance to
-2-compression for an expanded stent and provides increased side branch access, among other things. Also, the stents of this invention are longitudinally flexible.
The invention is also directed to a stent of generally cylindrical shape composed of at least one multibonate cell structure and desirably of a plurality of interconnected multibonate cell structures, as defined below. The multibonate structures may be interlocking and may be regularly arranged.
The invention contemplates stents having only one type of multibonate cell structure present as well as stents having a plurality of different multibonate cell structures present. Stents comprised of a plurality of multibonate cell structures of different order are also contemplated.
The invention is also directed to a stent comprised of a plurality of interlocking cell structures selected from the group consisting of bonate cell structures oriented at an oblique angle relative to the longitudinal axis of the stent, multibonate cell structures and combinations thereof.
Brief Description of the Figures Figure 1 is a flat plan view of an embodiment of a stent configuration of the invention in the unexpanded condition in which the cells share common elements;
Figure 2 is an end view of a tubular stent of Figure 1 according to the invention in its normal unexpanded condition;
Figure 3 is a detail view of a portion of Figure 1, as indicated;
Figure 4 is a view of the stent of Figures 1 and 2 showing the expanded condition;
Figure 5 is another embodiment of the invention, similar in view to that of Figure 1, showing the flat plan of the stent in the unexpanded condition;
Figure 6 is a detail view of a portion of Figure 5, as indicated;
Figure 7 is a flat plan view of another cell configuration according to the invention;
Figure 8 is a schematic showing of yet another cell configuration;
Figure 9 is a flat plan view showing a form of interconnection between cells;
Figure 10 is a flat plan view showing another form of interconnection between cells;
_v vll%I:i=P4 111JEP.CHEN O6 CA 02322134 2000-08-2212 563 3001, +4-9 89 2--- ' , - -
The invention is also directed to a stent of generally cylindrical shape composed of at least one multibonate cell structure and desirably of a plurality of interconnected multibonate cell structures, as defined below. The multibonate structures may be interlocking and may be regularly arranged.
The invention contemplates stents having only one type of multibonate cell structure present as well as stents having a plurality of different multibonate cell structures present. Stents comprised of a plurality of multibonate cell structures of different order are also contemplated.
The invention is also directed to a stent comprised of a plurality of interlocking cell structures selected from the group consisting of bonate cell structures oriented at an oblique angle relative to the longitudinal axis of the stent, multibonate cell structures and combinations thereof.
Brief Description of the Figures Figure 1 is a flat plan view of an embodiment of a stent configuration of the invention in the unexpanded condition in which the cells share common elements;
Figure 2 is an end view of a tubular stent of Figure 1 according to the invention in its normal unexpanded condition;
Figure 3 is a detail view of a portion of Figure 1, as indicated;
Figure 4 is a view of the stent of Figures 1 and 2 showing the expanded condition;
Figure 5 is another embodiment of the invention, similar in view to that of Figure 1, showing the flat plan of the stent in the unexpanded condition;
Figure 6 is a detail view of a portion of Figure 5, as indicated;
Figure 7 is a flat plan view of another cell configuration according to the invention;
Figure 8 is a schematic showing of yet another cell configuration;
Figure 9 is a flat plan view showing a form of interconnection between cells;
Figure 10 is a flat plan view showing another form of interconnection between cells;
_v vll%I:i=P4 111JEP.CHEN O6 CA 02322134 2000-08-2212 563 3001, +4-9 89 2--- ' , - -
-3-Figure 11 is a flat plan view showing yet another embodiment of the invention;
Figure 12 is a flat plaa view showing a bonate cell structure;
F igure 13 is a flat plan view showing a cnultibonate (tribonate) cell structure;
Figure 14a is a flat plan view showing yet another tribonate embodiment of the invention;
Figure 14b is a flat plan view showing the rotational axis of symmetry of the multibonate cells of Fig. 14a;
Figute 14c is a flat plan view showing the planes of reflectional syuimetry of the mu.ltibonate cells of Fig. 14a;
Figure 15a is a flat plan view showing yet another tribonate ennbodiment of the invention;
Figure 15b is a flat plan view showing the plane of reflectional syrnmetry of the rnultbonate cells of Fig. 15b;
Figure 16a is a flat plan view showing yet another tribonate cnobodiment of the invention;
Figure 16b is a side elevational view of the stent of Fig. 16a;
Figure 16c is a three dimensional isometric view of the stent of Fig. 16a;
Figure 16d is a magnified view of an end portion of the stent as shown in Fig. 16c;
Figure 16e is a throe dimensional isometric view of a stent similar lo that of Fig. 16c, but shorter;
Figure 17 is a flat plan view showing yet another embodiment of the invention which includes tribonate and bonate structures;
Figure 18 is a flat plan view showing yet another embodiment of the invention which includes tribonate and bonate structures;
Figure 19 is a flat plan view sbowing a quadribonate embodiment of the invention;
Figure 20a is a flat plan view showing yet another quadzibonate embodiment of the invention;
k igure 20b is an enl3rged portion of Fig. 20a showing the various planes Of synlnletLy;
AMENDED SHEET
Figure 12 is a flat plaa view showing a bonate cell structure;
F igure 13 is a flat plan view showing a cnultibonate (tribonate) cell structure;
Figure 14a is a flat plan view showing yet another tribonate embodiment of the invention;
Figure 14b is a flat plan view showing the rotational axis of symmetry of the multibonate cells of Fig. 14a;
Figute 14c is a flat plan view showing the planes of reflectional syuimetry of the mu.ltibonate cells of Fig. 14a;
Figure 15a is a flat plan view showing yet another tribonate ennbodiment of the invention;
Figure 15b is a flat plan view showing the plane of reflectional syrnmetry of the rnultbonate cells of Fig. 15b;
Figure 16a is a flat plan view showing yet another tribonate cnobodiment of the invention;
Figure 16b is a side elevational view of the stent of Fig. 16a;
Figure 16c is a three dimensional isometric view of the stent of Fig. 16a;
Figure 16d is a magnified view of an end portion of the stent as shown in Fig. 16c;
Figure 16e is a throe dimensional isometric view of a stent similar lo that of Fig. 16c, but shorter;
Figure 17 is a flat plan view showing yet another embodiment of the invention which includes tribonate and bonate structures;
Figure 18 is a flat plan view showing yet another embodiment of the invention which includes tribonate and bonate structures;
Figure 19 is a flat plan view sbowing a quadribonate embodiment of the invention;
Figure 20a is a flat plan view showing yet another quadzibonate embodiment of the invention;
k igure 20b is an enl3rged portion of Fig. 20a showing the various planes Of synlnletLy;
AMENDED SHEET
-4-Figure 21 a is a flat plan view showing yet another tribonate embodiment of the invention;
Figure 21 b is an enlarged portion of Fig. 21 a showing the various planes of symmetry;
Figure 22a is a flat plan view showing yet an embodiment of the invention which includes tribonate and quadribonate cells;
Figure 22b is an enlarged portion of Fig. 22a; and Figure 23 is a flat plan view showing an embodiment of the invention including obliquely oriented bonate cells.
Detailed Description An embodiment of a generally cylindrical stent 10 according to the invention is illustrated in Figures 1-4. It comprises a metal tube as shown in the Figure 2 end view, such as Nitinol, or stainless steel preferably, which has been etched or more preferably laser cut to the configuration shown in the flat plan view of Figure 1. The configuration may be formed in flat sheet, rolled into a cylinder and welded or the like, or the configuration may be formed directly from a small tube such as a hypotube. An enlarged detail of Figure 1 is shown in Figure 3. 'rhis configuration is made up of a series of generally triangular-like expansion cell elements generally indicated at 11 (see darkened cell in the Figures for clarity) having relatively straight segments 13, 15 and 17, relatively straight segments 12, 14 and 16 and curvilinear segments 18-23.
Segments 12, 14 and 16 comprise a first set of three segments arranged relative to each other in triangular spaced positions as shown in Figure 3. Segments 13, 15 and 17 are placed in triangular spaced positions also but are outwardly positioned with respect to inwardly positioned segments 12, 14 and 16 and are placed opposite paired ends of 12/16, 16/14 and 12/14 as shown. In this embodiment these segments 12-17 are all straight. Curvilinear segments 18, 19, 20, 21, 22 and 23 interconnect segments 12/13, 13/16, 16/17, 14/17, 14/15 and 12/15 as shown. I'referably the segments are curvilinear, more preferably they are S-shaped as shown, although they can be made up of one or more straight sections. The resultant cell exhibits the triskelion configuration, having the three part axis 25 radiating from a common center. Cells 11 in this embodiment are arranged in an internested arrangement or network as shown in the Figures with adjacent cells sharing common sides or segments.
Figure 21 b is an enlarged portion of Fig. 21 a showing the various planes of symmetry;
Figure 22a is a flat plan view showing yet an embodiment of the invention which includes tribonate and quadribonate cells;
Figure 22b is an enlarged portion of Fig. 22a; and Figure 23 is a flat plan view showing an embodiment of the invention including obliquely oriented bonate cells.
Detailed Description An embodiment of a generally cylindrical stent 10 according to the invention is illustrated in Figures 1-4. It comprises a metal tube as shown in the Figure 2 end view, such as Nitinol, or stainless steel preferably, which has been etched or more preferably laser cut to the configuration shown in the flat plan view of Figure 1. The configuration may be formed in flat sheet, rolled into a cylinder and welded or the like, or the configuration may be formed directly from a small tube such as a hypotube. An enlarged detail of Figure 1 is shown in Figure 3. 'rhis configuration is made up of a series of generally triangular-like expansion cell elements generally indicated at 11 (see darkened cell in the Figures for clarity) having relatively straight segments 13, 15 and 17, relatively straight segments 12, 14 and 16 and curvilinear segments 18-23.
Segments 12, 14 and 16 comprise a first set of three segments arranged relative to each other in triangular spaced positions as shown in Figure 3. Segments 13, 15 and 17 are placed in triangular spaced positions also but are outwardly positioned with respect to inwardly positioned segments 12, 14 and 16 and are placed opposite paired ends of 12/16, 16/14 and 12/14 as shown. In this embodiment these segments 12-17 are all straight. Curvilinear segments 18, 19, 20, 21, 22 and 23 interconnect segments 12/13, 13/16, 16/17, 14/17, 14/15 and 12/15 as shown. I'referably the segments are curvilinear, more preferably they are S-shaped as shown, although they can be made up of one or more straight sections. The resultant cell exhibits the triskelion configuration, having the three part axis 25 radiating from a common center. Cells 11 in this embodiment are arranged in an internested arrangement or network as shown in the Figures with adjacent cells sharing common sides or segments.
-5-Finally, the longitudinal axis of the stent is indicated by reference numera1270 in the above figures and in all of the remaining figures of the application.
When the stent of Figures 1 and 2 is expanded, as shown in Figure 4, on a balloon for example (not shown), the cells 11 take on a new configuration as shown, the segments making up the stent being indicated by the same numbers as used in Figures 1 and 3.
Referring now to Figures 5-6, another internested stent embodiment is shown. In this embodiment, as seen in Figures 5 and 6, expansion cells 11, best seen in the detail of Figure 6 (again a cell is indicated by darkening) are shaped the same as cells 11 in Figures 1-3. However, they are skewed with respect to the longitudinal axis 270 of the stent rather than being arranged in parallel longitudinal lines in which the cells are positioned perpendicular to the longitudinal axis of the stent as in Figures 1-4.
Referring now to Figure 7, another cell configuration is shown to demonstrate that elements or segments 12, 14 and 16 need not be straight but may be arcuate as shown, either inwardly as shown in the Figure or outwardly.
The cell configuration shown in Figure 8 is a three-lobed configuration preferably used in an interconnected cellular arrangement with individual connecting members as discussed in Figures 9 and 10. In this embodiment three sections, 12a/12bm 14a/14bm and 16a/16b, radiate from a common center to terminate in enlarged end portions 13, 15 and 17, respectively. However, Figures 9 and 10 make use of cell configurations similar to those shown in Figures 1-6.
In Figure 9, a series of sets of cells, each set consisting of six cells 11 arranged in a circular pattern 28, repeated throughout the stent body. Each cell 11 is connected to three adjacent cells 11 by three connector segments 30 in a repeating pattern through the stent body. In this particular arrangement, the connector members extend from an inner segment on one cell to an inner segment on an adjacent cell, as shown. The connector members may be straight or curved and may be in various shapes such as zig-zag or S-shaped, etc.
In Figure 10 the connector members 30 extend from an inner segment on 30 one cell to an outer segment on the adjacent cell as shown. Cells 11 are arranged in vertical rows in this embodiment but are staggered longitudinally as can be seen in the Figures.
When the stent of Figures 1 and 2 is expanded, as shown in Figure 4, on a balloon for example (not shown), the cells 11 take on a new configuration as shown, the segments making up the stent being indicated by the same numbers as used in Figures 1 and 3.
Referring now to Figures 5-6, another internested stent embodiment is shown. In this embodiment, as seen in Figures 5 and 6, expansion cells 11, best seen in the detail of Figure 6 (again a cell is indicated by darkening) are shaped the same as cells 11 in Figures 1-3. However, they are skewed with respect to the longitudinal axis 270 of the stent rather than being arranged in parallel longitudinal lines in which the cells are positioned perpendicular to the longitudinal axis of the stent as in Figures 1-4.
Referring now to Figure 7, another cell configuration is shown to demonstrate that elements or segments 12, 14 and 16 need not be straight but may be arcuate as shown, either inwardly as shown in the Figure or outwardly.
The cell configuration shown in Figure 8 is a three-lobed configuration preferably used in an interconnected cellular arrangement with individual connecting members as discussed in Figures 9 and 10. In this embodiment three sections, 12a/12bm 14a/14bm and 16a/16b, radiate from a common center to terminate in enlarged end portions 13, 15 and 17, respectively. However, Figures 9 and 10 make use of cell configurations similar to those shown in Figures 1-6.
In Figure 9, a series of sets of cells, each set consisting of six cells 11 arranged in a circular pattern 28, repeated throughout the stent body. Each cell 11 is connected to three adjacent cells 11 by three connector segments 30 in a repeating pattern through the stent body. In this particular arrangement, the connector members extend from an inner segment on one cell to an inner segment on an adjacent cell, as shown. The connector members may be straight or curved and may be in various shapes such as zig-zag or S-shaped, etc.
In Figure 10 the connector members 30 extend from an inner segment on 30 one cell to an outer segment on the adjacent cell as shown. Cells 11 are arranged in vertical rows in this embodiment but are staggered longitudinally as can be seen in the Figures.
-6-Figure 11 is illustrative of an internested stent configuration in which all segments of each cell are straight as opposed to curvilinear.
For the purposes of this disclosure, the term 'bonate' refers to a structure which has relatively wide end portions joined by a connecting portion which is, at least in part, relatively narrow. A bonate cell structure is illustrated generally at 100 in Fig.
12. Bonate cell structure 100 has a first relatively wide end portion 104 of the cell and a second relatively wide end portion 108 of the cell and a relatively narrow connecting portion 112 of the cell and resembles a dog bone. Connecting portion 112 may also be relatively narrow in only a portion thereof. Stents having bonate cell structures have been disclosed in commonly assigned US Pat. No. 6,013,091.
The term 'multibonate', for the purposes of this disclosure, refers to a structure which has three or more relatively wide end portions each of which is joined to a common portion via a relatively narrow connecting portion. Further, each of the end portions radiates from at least one common point in the common portion, desirably in the center of the common portion. The relatively wide end portions of a multibonate structure may be lobe shaped. Also desirably, each of the end portions emanates from a vertex region of the common portion. One such multibonate cell structure is shown generally at 120 in Fig. 13. Multibonate structure 120 consists of three relatively wide end portions 124 of the cell each of which is joined to a common portion 128 of the cell via relatively narrow connecting portions 132 of the cell. It is noted that each of end portions 124 extends from a common point 129. It is also noted that each of end portions 124 extends from a vertex 131 of common portion 128. The multibonate structure of Fig. 13 is also termed a tribonate structure because of the presence of the three end portions. Multibonate structures with four relatively wide end portions would similarly be termed 'quadribonate' and multibonate structures with five, six, seven and eight relatively wide end portions would be termed 'pentibonate', 'hexibonate', 'heptabonate' and 'octabonate', respectively. A multibonate structure with 'n' end portions is referred to as an 'n`'' order' multibonate structure.
The present invention is directed generally to stents formed of multibonate cell structures. In one embodiment, the invention is directed to a stent of generally cylindrical shape comprised of at least one multibonate cell structure and desirably of a plurality of interconnected multibonate cell structures. The multibonate
For the purposes of this disclosure, the term 'bonate' refers to a structure which has relatively wide end portions joined by a connecting portion which is, at least in part, relatively narrow. A bonate cell structure is illustrated generally at 100 in Fig.
12. Bonate cell structure 100 has a first relatively wide end portion 104 of the cell and a second relatively wide end portion 108 of the cell and a relatively narrow connecting portion 112 of the cell and resembles a dog bone. Connecting portion 112 may also be relatively narrow in only a portion thereof. Stents having bonate cell structures have been disclosed in commonly assigned US Pat. No. 6,013,091.
The term 'multibonate', for the purposes of this disclosure, refers to a structure which has three or more relatively wide end portions each of which is joined to a common portion via a relatively narrow connecting portion. Further, each of the end portions radiates from at least one common point in the common portion, desirably in the center of the common portion. The relatively wide end portions of a multibonate structure may be lobe shaped. Also desirably, each of the end portions emanates from a vertex region of the common portion. One such multibonate cell structure is shown generally at 120 in Fig. 13. Multibonate structure 120 consists of three relatively wide end portions 124 of the cell each of which is joined to a common portion 128 of the cell via relatively narrow connecting portions 132 of the cell. It is noted that each of end portions 124 extends from a common point 129. It is also noted that each of end portions 124 extends from a vertex 131 of common portion 128. The multibonate structure of Fig. 13 is also termed a tribonate structure because of the presence of the three end portions. Multibonate structures with four relatively wide end portions would similarly be termed 'quadribonate' and multibonate structures with five, six, seven and eight relatively wide end portions would be termed 'pentibonate', 'hexibonate', 'heptabonate' and 'octabonate', respectively. A multibonate structure with 'n' end portions is referred to as an 'n`'' order' multibonate structure.
The present invention is directed generally to stents formed of multibonate cell structures. In one embodiment, the invention is directed to a stent of generally cylindrical shape comprised of at least one multibonate cell structure and desirably of a plurality of interconnected multibonate cell structures. The multibonate
-7-cell structures may optionally be regularly arranged. One such stent is shown in the flat in Fig. 14a. Stent 200 consists of a plurality of interconnected tribonate cell structures 120. Tribonate cell structures are arranged in interconnected longitudinal rows 204.
Tribonate cell structures within a row are seen to be tessellated or interlocking with adjacent cell structures having at least one member 124a in common. Member 124 simultaneously serves as an end portion of a cell structure and as a portion of the central portion of a cell structure. Tribonate cell structures 120 in adjacent rows 204 are also seen to share a member 124b in common. Member 124b, similarly, serves as an end portion in one cell structure and as a portion of the central portion of a cell in an adjacent row. All of the tribonate structures 120 in adjacent rows 204 of multibonate structures are identically oriented relative to the longitudinal axis of the stent.
It is further noted that tribonate cells 120 of Fig. 14a have a common portion 128 which is substantially triangular and moreover formed substantially in an equilateral triangle. Each tribonate cell 120 has a threefold rotational axis of symmetry (C3 axis of symmetry) 121 in the flat, through the center of the cell, as shown in Fig.
14b. Each tribonate structure further is characterized by three planes of reflectional symmetry (a,) 123a-c, as shown in Fig. 14c. To that end, first, second and third end portions 124a-c, respectively, are the same shape. Moreover, all three connecting portions 132a-c are substantially the same shape, width and length.
The invention further contemplates variations on the multibonate structure in general and the tribonate structure in particular. One such variation is shown in stent 200 in Fig. 15a. Tribonate cell structure 120 is not seen to possess the threefold rotational symmetry of the tribonate cell structure of Fig. 14a.
Moreover, cells 120 are seen to possess only a single plane of reflectional symmetry (a") 123, as shown in Fig. 15b. The cell structure is also seen to vary in that second and third end portions 124b,c are a reflection of one another while end portion 124a differs in shape. End portion 124a is substantially triangular in shape. Its boundaries are defmed by two convex side portions 136a,b. End portions 124b,c are each seen to be mushroom shaped. Each of end portions 124a-c extend from connecting portions 132a-c, respectively, which in turn, extend from common portion 128. End portions 124a-c are seen to be mushroom shaped.
Another embodiment of the invention is shown generally at 200 in Figs.
16a-e. As in Fig. 15, tribonate cell structure 120 does not possess the threefold
Tribonate cell structures within a row are seen to be tessellated or interlocking with adjacent cell structures having at least one member 124a in common. Member 124 simultaneously serves as an end portion of a cell structure and as a portion of the central portion of a cell structure. Tribonate cell structures 120 in adjacent rows 204 are also seen to share a member 124b in common. Member 124b, similarly, serves as an end portion in one cell structure and as a portion of the central portion of a cell in an adjacent row. All of the tribonate structures 120 in adjacent rows 204 of multibonate structures are identically oriented relative to the longitudinal axis of the stent.
It is further noted that tribonate cells 120 of Fig. 14a have a common portion 128 which is substantially triangular and moreover formed substantially in an equilateral triangle. Each tribonate cell 120 has a threefold rotational axis of symmetry (C3 axis of symmetry) 121 in the flat, through the center of the cell, as shown in Fig.
14b. Each tribonate structure further is characterized by three planes of reflectional symmetry (a,) 123a-c, as shown in Fig. 14c. To that end, first, second and third end portions 124a-c, respectively, are the same shape. Moreover, all three connecting portions 132a-c are substantially the same shape, width and length.
The invention further contemplates variations on the multibonate structure in general and the tribonate structure in particular. One such variation is shown in stent 200 in Fig. 15a. Tribonate cell structure 120 is not seen to possess the threefold rotational symmetry of the tribonate cell structure of Fig. 14a.
Moreover, cells 120 are seen to possess only a single plane of reflectional symmetry (a") 123, as shown in Fig. 15b. The cell structure is also seen to vary in that second and third end portions 124b,c are a reflection of one another while end portion 124a differs in shape. End portion 124a is substantially triangular in shape. Its boundaries are defmed by two convex side portions 136a,b. End portions 124b,c are each seen to be mushroom shaped. Each of end portions 124a-c extend from connecting portions 132a-c, respectively, which in turn, extend from common portion 128. End portions 124a-c are seen to be mushroom shaped.
Another embodiment of the invention is shown generally at 200 in Figs.
16a-e. As in Fig. 15, tribonate cell structure 120 does not possess the threefold
-8- -rotational symmetry of the tribonate cell structure of Fig. 13. Moreover, cells 120 are seen to possess only a single plane of reflectional symmetry (aõ). The cell structure is also seen to vary in that second and third end portions 124b,c are a reflection of one another while end portion 124a differs in shape. End portion 124a is substantially triangular in shape. Its boundaries are defined by two substantially straight side portions 136a,b. End portions 124b,c are each slot shaped.
In another embodiment, the invention is directed to a stent, as shown generally at 200 in Fig. 17. Stent 200 is composed of a plurality of connected tribonate cell structures 120 arranged in longitudinal rows 204. The stent further comprises a plurality of bonate cell structures 140 arranged in longitudinal rows 208 and extending between adjacent rows 204 of tribonate cells 120. Bonate cell structures 140 serve as connectors between adjacent rows of multibonate cells. Bonate cell structures 140 are disposed at an oblique angle relative to the longitudinal axis of the stent.
Adjacent rows of bonate cell structures 140 are disposed at equal but opposite angles relative to the longitudinal axis 270 of the stent 200. Bonate cell structures 140 and multibonate cell structures 120 are seen to interlock with one another. End portions 104 of bonate structures 140 form a portion of the side of common portion 128 of tribonate cell structures 120. Similarly, end portions 124b,c of tribonate cell structures 120 form a portion of narrow connecting portion 112 of bonate cell structures 140. Within a longitudinal row 204 of tribonate structures, adjacent tribonate cell structures interlock as well with end portion 124a of a cell forming a part of common portion 128 of an adjacent cell.
The stent of Fig. 17 also differs from the previously shown stents in that tribonate cell structures in adjacent row 204 of tribonate cell structures are oppositely oriented - the cell structures in adjacent rows are rotated by 180 relative to one another.
For example, end portions 124a of cell structures in row 204a is directed in an opposite direction relative to end portions 124a of cell structures in row 204b.
Another embodiment of the stent is shown generally at 200 in Fig. 18.
Stent 200 is formed of a plurality of multibonate (tribonate) cells 120 and bonate cells 140. The stent of Fig. 18 is similar to that of Fig. 17 differing in the shape of end portions 124a. End portion 124a is substantially triangular.
In the embodiments of Figs. 14 and 17, tribonate cell structures include an end portion 124a which is oriented perpendicular to the longitudinal axis of the stent.
In another embodiment, the invention is directed to a stent, as shown generally at 200 in Fig. 17. Stent 200 is composed of a plurality of connected tribonate cell structures 120 arranged in longitudinal rows 204. The stent further comprises a plurality of bonate cell structures 140 arranged in longitudinal rows 208 and extending between adjacent rows 204 of tribonate cells 120. Bonate cell structures 140 serve as connectors between adjacent rows of multibonate cells. Bonate cell structures 140 are disposed at an oblique angle relative to the longitudinal axis of the stent.
Adjacent rows of bonate cell structures 140 are disposed at equal but opposite angles relative to the longitudinal axis 270 of the stent 200. Bonate cell structures 140 and multibonate cell structures 120 are seen to interlock with one another. End portions 104 of bonate structures 140 form a portion of the side of common portion 128 of tribonate cell structures 120. Similarly, end portions 124b,c of tribonate cell structures 120 form a portion of narrow connecting portion 112 of bonate cell structures 140. Within a longitudinal row 204 of tribonate structures, adjacent tribonate cell structures interlock as well with end portion 124a of a cell forming a part of common portion 128 of an adjacent cell.
The stent of Fig. 17 also differs from the previously shown stents in that tribonate cell structures in adjacent row 204 of tribonate cell structures are oppositely oriented - the cell structures in adjacent rows are rotated by 180 relative to one another.
For example, end portions 124a of cell structures in row 204a is directed in an opposite direction relative to end portions 124a of cell structures in row 204b.
Another embodiment of the stent is shown generally at 200 in Fig. 18.
Stent 200 is formed of a plurality of multibonate (tribonate) cells 120 and bonate cells 140. The stent of Fig. 18 is similar to that of Fig. 17 differing in the shape of end portions 124a. End portion 124a is substantially triangular.
In the embodiments of Figs. 14 and 17, tribonate cell structures include an end portion 124a which is oriented perpendicular to the longitudinal axis of the stent.
-9-The invention also contemplates stents in which multibonate cells include an end portion which is parallel to the longitudinal axis of the stent. Such a stent is shown generally at 10 in Fig. 1. End portions 124b are aligned parallel to the longitudinal axis 270 of the stent.
Yet another embodiment of the invention is shown generally at 200 in Fig. 19. Stent 200 is comprised of a series of interconnected, intemested quadribonate cells 120 including first quadribonate cells 120a and second quadribonate cells 120b.
First and second quadribonate cell 120a,b are differently shaped. End portions 124a of first quadribonate cells 120a also serve as side portions of adjacent second quadribonate cells 120b. First quadribonate cells 120a are joined together by connecting members 154 which also serve as end portions 124b for quadribonate cells 120b. End portions 124a of first quadribonate cell structures 120a are oriented at oblique angles relative to longitudinal axis 270. End portions 124b of second quadribonate cell structures 120b are oriented parallel or perpendicular to longitudinal axis 270 of stent 200.
The stent of Fig. 19 is an example of a multibonate stent which consists of at least two different types of multibonate cells of the same order.
Another quadribonate stent is shown generally at 200 in Fig. 20a. Stent 200 is formed of a series of interconnected, intemested quadribonate cells 120 including first quadribonate 120a and second quadribonate cells 120b. End portions 124a of first quadribonate cell structures 120a are oriented at oblique angles relative to longitudinal axis 270. End portions 124b of second quadribonate cell structures 120b are oriented parallel or perpendicular to longitudinal axis 270 of stent 200. Stent 200 further includes bonate cell structures 140 oriented at oblique angles relative to the longitudinal axis 270 of the stent. The stent of Fig. 20a is an example of a multibonate stent which consists of at least two different types of multibonate cells of the same order and further contains bonate cells.
The quadribonate cells of Figs. 19 and 20 have a four-fold axis of rotational symmetry. Fig. 20b shows this axis 121 for one quadribonate cell 120b of Fig. 20a. The quadribonate cells also are characterized by four planes of reflectional symmetry 123a-d.
The invention is also directed to a stent, shown generally at 200 in Fig.
21 a, which includes elongated tribonate cell structures 120 as well as a row of bonate cell structures 140 at one end of the stent. Tribonate cells 120 include a relatively long,
Yet another embodiment of the invention is shown generally at 200 in Fig. 19. Stent 200 is comprised of a series of interconnected, intemested quadribonate cells 120 including first quadribonate cells 120a and second quadribonate cells 120b.
First and second quadribonate cell 120a,b are differently shaped. End portions 124a of first quadribonate cells 120a also serve as side portions of adjacent second quadribonate cells 120b. First quadribonate cells 120a are joined together by connecting members 154 which also serve as end portions 124b for quadribonate cells 120b. End portions 124a of first quadribonate cell structures 120a are oriented at oblique angles relative to longitudinal axis 270. End portions 124b of second quadribonate cell structures 120b are oriented parallel or perpendicular to longitudinal axis 270 of stent 200.
The stent of Fig. 19 is an example of a multibonate stent which consists of at least two different types of multibonate cells of the same order.
Another quadribonate stent is shown generally at 200 in Fig. 20a. Stent 200 is formed of a series of interconnected, intemested quadribonate cells 120 including first quadribonate 120a and second quadribonate cells 120b. End portions 124a of first quadribonate cell structures 120a are oriented at oblique angles relative to longitudinal axis 270. End portions 124b of second quadribonate cell structures 120b are oriented parallel or perpendicular to longitudinal axis 270 of stent 200. Stent 200 further includes bonate cell structures 140 oriented at oblique angles relative to the longitudinal axis 270 of the stent. The stent of Fig. 20a is an example of a multibonate stent which consists of at least two different types of multibonate cells of the same order and further contains bonate cells.
The quadribonate cells of Figs. 19 and 20 have a four-fold axis of rotational symmetry. Fig. 20b shows this axis 121 for one quadribonate cell 120b of Fig. 20a. The quadribonate cells also are characterized by four planes of reflectional symmetry 123a-d.
The invention is also directed to a stent, shown generally at 200 in Fig.
21 a, which includes elongated tribonate cell structures 120 as well as a row of bonate cell structures 140 at one end of the stent. Tribonate cells 120 include a relatively long,
-10-but relatively narrow connecting portion 132a and relatively short and relatively narrow connecting portions 132b. Tribonate cells 120 have a plane of reflectional symmetry 123a as shown in Fig. 21b.
Another embodiment of the inventive stent is shown generally at 200 in Fig. 22a. The pattern of Fig. 22a is magnified in Fig. 22b. Stent 200 is formed of interconnected tribonate cells 120a and interconnected quadribonate cells 120b.
Tribonate cells 120a are formed of three relatively wide end portions 124a, each of which is joined to a common portion 128a of the cell via relatively narrow connecting portions 132a. Quadribonate cells 120b are formed of a four relatively wide end portions 124b each of which is joined to a common portion 128b of the cell via relatively narrow connecting portions 132b.
The stent of Fig. 22a also consists of a plurality of interconnected five member spirals 160a, four member spirals 160b and three member spirals 160c.
Five member spirals 160a each have five members 163a spiraling about a center portion 165a, four member spirals 160b each have four members 163b spiraling about a center portion 165b and three member spirals 160c each have three members 163c spiraling about a center portion 165c.
Stents having spiral members have also been disclosed in commonly assigned US Pat. No. 6,033,433.
More generally, the invention is directed to stents having multibonate cell structures which include at least one end portion disposed parallel to the longitudinal axis of the stent as well as multibonate cell structures which include at least one end portion disposed perpendicular to the longitudinal axis of the stent.
The invention further contemplates stents which comprise multibonate cell structure in which none of the end portions are perpendicular or parallel to the longitudinal axis of the stent. Such a stent is shown generally at 200 in Fig.
22a. Each of end portions 124a-c are obliquely oriented relative to the longitudinal axis of the stent.
The invention is also directed more generally to stents comprising any order of multibonate structure. A stent comprising sixth order multibonate cell structures is shown generally at 10 in Fig. 9. Hexabonate cell structure 150 consists of six end portions 154 emanating from connector portions 162 which in turn emanate
Another embodiment of the inventive stent is shown generally at 200 in Fig. 22a. The pattern of Fig. 22a is magnified in Fig. 22b. Stent 200 is formed of interconnected tribonate cells 120a and interconnected quadribonate cells 120b.
Tribonate cells 120a are formed of three relatively wide end portions 124a, each of which is joined to a common portion 128a of the cell via relatively narrow connecting portions 132a. Quadribonate cells 120b are formed of a four relatively wide end portions 124b each of which is joined to a common portion 128b of the cell via relatively narrow connecting portions 132b.
The stent of Fig. 22a also consists of a plurality of interconnected five member spirals 160a, four member spirals 160b and three member spirals 160c.
Five member spirals 160a each have five members 163a spiraling about a center portion 165a, four member spirals 160b each have four members 163b spiraling about a center portion 165b and three member spirals 160c each have three members 163c spiraling about a center portion 165c.
Stents having spiral members have also been disclosed in commonly assigned US Pat. No. 6,033,433.
More generally, the invention is directed to stents having multibonate cell structures which include at least one end portion disposed parallel to the longitudinal axis of the stent as well as multibonate cell structures which include at least one end portion disposed perpendicular to the longitudinal axis of the stent.
The invention further contemplates stents which comprise multibonate cell structure in which none of the end portions are perpendicular or parallel to the longitudinal axis of the stent. Such a stent is shown generally at 200 in Fig.
22a. Each of end portions 124a-c are obliquely oriented relative to the longitudinal axis of the stent.
The invention is also directed more generally to stents comprising any order of multibonate structure. A stent comprising sixth order multibonate cell structures is shown generally at 10 in Fig. 9. Hexabonate cell structure 150 consists of six end portions 154 emanating from connector portions 162 which in turn emanate
-11- -from a common portion 166. The invention contemplates stents in which adjacent multibonate structures have at least one side in common, as shown in Fig. 9, as well as stent in which adjacent multibonate structures do not have at least one side in common.
The invention is also directed to stents comprising at least one multibonate structure of nth order and at least one bonate structure or multibonate structure of mth order where n and m are integers, n and m are greater than 2 and n*m.
These stents comprise at least one multibonate structure of a desired order and one bonate structure or multibonate structure of a different order.
The stent of Fig. 9 comprises sixth order multibonate structures (hexabonate) 150 as well as third order (tribonate) structures 120. The different order multibonate structures may be interlocking, having parts in common. Tribonate structures 120 in Fig. 9 are interconnected by connecting segments 154 which also serve as end portions of hexabonate cell structures 150. The different order multibonate structures may also be separate from one another and interconnected via connecting members.
The invention also contemplates stents formed of at least two different types of multibonate cell structures of the same order. For example, the two different types of multibonate cells may have different dimensions or different shapes.
This is illustrated in Fig. 10. The stent, shown in the flat, includes first tribonate cells 120a and second tribonate cells 120b. The shape of first tribonate cells 120a differs from that of second tribonate cells 120b. Figure 19 similarly includes two different types of quadribonate cells 120a,b.
The invention is also directed to a stent comprised of at least one cell structure selected from the group consisting of bonate cell structures oriented at an oblique angle relative to the longitudinal axis of the stent, multibonate cell structures and combinations thereof. Desirably, the stent will be composed comprised of a plurality of cell structures selected from the group consisting of bonate cell structures oriented at an oblique angle relative to the longitudinal axis of the stent, multibonate cell structures and combinations thereof. Optionally, the cell structures will be interlocking.
The invention is further directed to a stent comprising one or more bonate structures oriented at an oblique angle relative to the longitudinal axis of the stent. As shown in the flat in Fig. 23, stent 200 consists of interconnected bonate cell structures 140. The stent includes first bonate cell structures 140a which are oriented at
The invention is also directed to stents comprising at least one multibonate structure of nth order and at least one bonate structure or multibonate structure of mth order where n and m are integers, n and m are greater than 2 and n*m.
These stents comprise at least one multibonate structure of a desired order and one bonate structure or multibonate structure of a different order.
The stent of Fig. 9 comprises sixth order multibonate structures (hexabonate) 150 as well as third order (tribonate) structures 120. The different order multibonate structures may be interlocking, having parts in common. Tribonate structures 120 in Fig. 9 are interconnected by connecting segments 154 which also serve as end portions of hexabonate cell structures 150. The different order multibonate structures may also be separate from one another and interconnected via connecting members.
The invention also contemplates stents formed of at least two different types of multibonate cell structures of the same order. For example, the two different types of multibonate cells may have different dimensions or different shapes.
This is illustrated in Fig. 10. The stent, shown in the flat, includes first tribonate cells 120a and second tribonate cells 120b. The shape of first tribonate cells 120a differs from that of second tribonate cells 120b. Figure 19 similarly includes two different types of quadribonate cells 120a,b.
The invention is also directed to a stent comprised of at least one cell structure selected from the group consisting of bonate cell structures oriented at an oblique angle relative to the longitudinal axis of the stent, multibonate cell structures and combinations thereof. Desirably, the stent will be composed comprised of a plurality of cell structures selected from the group consisting of bonate cell structures oriented at an oblique angle relative to the longitudinal axis of the stent, multibonate cell structures and combinations thereof. Optionally, the cell structures will be interlocking.
The invention is further directed to a stent comprising one or more bonate structures oriented at an oblique angle relative to the longitudinal axis of the stent. As shown in the flat in Fig. 23, stent 200 consists of interconnected bonate cell structures 140. The stent includes first bonate cell structures 140a which are oriented at
-12-a first oblique angle relative to the longitudinal axis of the stent 270 and second bonate cell structures 140b which are oriented at a second oblique angle relative to the longitudinal axis of the stent.
The second oblique angle is equal but opposite to the first oblique angle. The stent of Fig. 23 consists of alternating rows 280a and 280b of first bonate cell structures 140a and second bonate cell structures 140b, respectively, disposed about the circumference of the stent.
All of the configurations shown in the Figures may be utilized uniformly throughout a stent or they may be mixed as a means of tailoring a variety of different characteristics throughout various regions of a stent. Other cell configurations may also be used in the practice of the invention.
It is understood that the invention contemplates substituting straight sections of the cell structure for curved structures and vice versa as long as the multibonate structure of the cells is maintained.
It is also understood that the term stent, as used in this application, is directed to stents, stent-grafts, grafts and other endoluminal and intraluminal prostheses.
For example, the configurations disclosed herein may be used as a framework for grafts.
It will be also appreciated that, while the specific shapes depicted in the figures hereof contain many functional features, those functional features can all readily be obtained in other embodiments which have an overall appearance which is quite different. Therefore, the article of the figures is considered to have a novel and non-obvious ornamental appearance independent of the functional features described herein.
While this invention may be embodied in many different forms, there are described in detail herein specific preferred embodiments of the invention.
This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto.
F:IWPWORK1IG17224-APP.121
The second oblique angle is equal but opposite to the first oblique angle. The stent of Fig. 23 consists of alternating rows 280a and 280b of first bonate cell structures 140a and second bonate cell structures 140b, respectively, disposed about the circumference of the stent.
All of the configurations shown in the Figures may be utilized uniformly throughout a stent or they may be mixed as a means of tailoring a variety of different characteristics throughout various regions of a stent. Other cell configurations may also be used in the practice of the invention.
It is understood that the invention contemplates substituting straight sections of the cell structure for curved structures and vice versa as long as the multibonate structure of the cells is maintained.
It is also understood that the term stent, as used in this application, is directed to stents, stent-grafts, grafts and other endoluminal and intraluminal prostheses.
For example, the configurations disclosed herein may be used as a framework for grafts.
It will be also appreciated that, while the specific shapes depicted in the figures hereof contain many functional features, those functional features can all readily be obtained in other embodiments which have an overall appearance which is quite different. Therefore, the article of the figures is considered to have a novel and non-obvious ornamental appearance independent of the functional features described herein.
While this invention may be embodied in many different forms, there are described in detail herein specific preferred embodiments of the invention.
This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto.
F:IWPWORK1IG17224-APP.121
Claims (35)
1. A stent of generally cylindrical shape comprised of at least one multibonate cell structure, the at least one multibonate cell structure having at least three relatively wide end portions, each of the at least three relatively wide end portions being joined to a common portion by a relatively narrow connecting portion, each of the relatively wide end portions radiating from a common point in the common portion.
2. The stent of claim 1 comprised of a plurality of interconnected multibonate cell structures.
3. The stent of claim 2 wherein the multibonate cell structures are regularly arranged.
4. The stent of claim 2 wherein at least some of the multibonate cell structures are tribonate, each tribonate structure having a common portion;
a first connecting portion extending from the common portion;
a first end portion extending from the first connecting portion;
a second connecting portion extending from the common portion;
a second end portion extending from the second connecting portion;
a third connecting portion extending from the common portion; and a third end portion extending from the third connecting portion.
a first connecting portion extending from the common portion;
a first end portion extending from the first connecting portion;
a second connecting portion extending from the common portion;
a second end portion extending from the second connecting portion;
a third connecting portion extending from the common portion; and a third end portion extending from the third connecting portion.
5. The stent of claim 4 wherein the multibonate structures are arranged in interconnected longitudinal rows.
6. The stent of claim 5 wherein all of the multibonate cell structures are tribonate.
7. The stent of claim 5 wherein adjacent rows of multibonate structures have connecting members extending therebetween.
8. The stent of claim 5 wherein adjacent multibonate structures within a row are interlocking.
9. The stent of claim 5 wherein adjacent rows of multibonate structures have connecting members extending therebetween, the connecting members being bonate cell structures.
10. The stent of claim 9 wherein each bonate cell structure is disposed at an oblique angle relative to the longitudinal axis.
11. The stent of claim 10 wherein the bonate cell structures are arranged in longitudinal rows, all of the bonate cells within a row disposed at the same oblique angle, bonate cell structures in adjacent rows of bonate structures oppositely disposed about a line parallel to the longitudinal axis of the stent extending between the adjacent rows of bonate structures and equidistant from the adjacent rows of bonate structures.
12. The stent of claim 6 wherein adjacent rows of tribonate structures are rotated 180° relative to one another.
13. The stent of claim 6 wherein adjacent rows of tribonate structures are identically oriented relative to the longitudinal axis of the stent.
14. The stent of claim 1 wherein each multibonate structure is defined by a plurality of interconnected side portions and at least some of the multibonate structures have a side portion in common.
15. The stent of claim 14 wherein the multibonate structures are tribonate.
16. The stent of claim 15 wherein the multibonate structures are disposed in longitudinal rows and adjacent multibonate structures in adjacent rows of multibonate structures share at least one side portion in common.
17. The stent of claim 6 wherein the tribonate structure has a threefold rotational axis of symmetry in the flat.
18. The stent of claim 6 wherein the tribonate structure has a single plane of reflectional symmetry .sigma. v.
19. The stent of claim 4 wherein the second and third connecting portions are substantially the same length.
20. The stent of claim 4 wherein all three connecting portions are substantially the same length.
21. The stent of claim 4 where at least one of the end portions is substantially triangular in shape.
22. The stent of claim 21 wherein the substantially triangular end portion has convex sides.
23. The stent of claim 4 wherein at least two of the end portions are substantially rectangular in shape.
24. The stent of claim 23 wherein the substantially rectangular end portions are formed of a first side portion extending from the connecting portion;
a second side portion opposite the first side portion and extending from the connecting portion; and an end base portion extending between the first and second side portions, wherein the base portion is substantially linear,
a second side portion opposite the first side portion and extending from the connecting portion; and an end base portion extending between the first and second side portions, wherein the base portion is substantially linear,
25. The stent of claim 23 wherein the substantially rectangular end portions are formed of a first side portion extending from the connecting portion;
a second side portion opposite the first side portion and extending from the connecting portion; and an end base portion extending between the first and second side portions, wherein the base portion is a convex curve.
a second side portion opposite the first side portion and extending from the connecting portion; and an end base portion extending between the first and second side portions, wherein the base portion is a convex curve.
26. The stent of claim 1 wherein at least some of the multibonate structures are hexabonate structures.
27. The stent of claim 26 wherein adjacent hexabonate structures have at least one side in common.
28. The stent of claim 26 further comprising tribonate structures.
29. The stent of claim 28 wherein the hexabonate and tribonate structures are interlocking.
30. The stent of claim 8 comprising at least one multibonate structure of n th order and at least one multibonate structure of m th order where n and m are integers greater than 2; and n .noteq. m.
31. The stent of claim 6 wherein the multibonate cell structures are of the same tribonate cell structure.
32. The stent of claim 4 further comprising interconnected quadribonate cell structures.
33. The stent of claim 1 comprised of a plurality of multibonate cell structures.
34. The stent of claim 1 comprising a plurality of multibonate cell structures of different order.
35. The stent of claim 33 wherein the cell structures are interlocking.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3666598A | 1998-03-04 | 1998-03-04 | |
| US09/036,665 | 1998-03-04 | ||
| PCT/US1999/004686 WO1999044543A1 (en) | 1998-03-04 | 1999-03-03 | Improved stent cell configurations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2322134A1 CA2322134A1 (en) | 1999-09-10 |
| CA2322134C true CA2322134C (en) | 2009-04-07 |
Family
ID=21889943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002322134A Expired - Fee Related CA2322134C (en) | 1998-03-04 | 1999-03-03 | Improved stent cell configurations |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US6395020B1 (en) |
| EP (2) | EP1059896B1 (en) |
| JP (1) | JP4351388B2 (en) |
| AT (2) | ATE471132T1 (en) |
| CA (1) | CA2322134C (en) |
| DE (2) | DE69931472T2 (en) |
| WO (1) | WO1999044543A1 (en) |
Families Citing this family (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7204848B1 (en) * | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
| EP0884029B1 (en) | 1997-06-13 | 2004-12-22 | Gary J. Becker | Expandable intraluminal endoprosthesis |
| US6013091A (en) * | 1997-10-09 | 2000-01-11 | Scimed Life Systems, Inc. | Stent configurations |
| US6755856B2 (en) | 1998-09-05 | 2004-06-29 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
| US6682554B2 (en) | 1998-09-05 | 2004-01-27 | Jomed Gmbh | Methods and apparatus for a stent having an expandable web structure |
| US20020019660A1 (en) * | 1998-09-05 | 2002-02-14 | Marc Gianotti | Methods and apparatus for a curved stent |
| DE19840645A1 (en) * | 1998-09-05 | 2000-03-09 | Jomed Implantate Gmbh | Stent |
| US7815763B2 (en) | 2001-09-28 | 2010-10-19 | Abbott Laboratories Vascular Enterprises Limited | Porous membranes for medical implants and methods of manufacture |
| US7887578B2 (en) | 1998-09-05 | 2011-02-15 | Abbott Laboratories Vascular Enterprises Limited | Stent having an expandable web structure |
| US8382821B2 (en) | 1998-12-03 | 2013-02-26 | Medinol Ltd. | Helical hybrid stent |
| US6368346B1 (en) | 1999-06-03 | 2002-04-09 | American Medical Systems, Inc. | Bioresorbable stent |
| EP1194079B1 (en) * | 1999-07-02 | 2005-06-01 | Endotex Interventional Systems, Inc. | Flexible, stretchable coiled-sheet stent |
| US20010047200A1 (en) * | 1999-10-13 | 2001-11-29 | Raymond Sun | Non-foreshortening intraluminal prosthesis |
| DE19951611A1 (en) * | 1999-10-26 | 2001-05-10 | Biotronik Mess & Therapieg | Stent with a closed structure |
| DE19957063A1 (en) * | 1999-11-26 | 2001-08-02 | Franz Herbst | Stent and method for its manufacture |
| SG86458A1 (en) | 2000-03-01 | 2002-02-19 | Medinol Ltd | Longitudinally flexible stent |
| US7141062B1 (en) | 2000-03-01 | 2006-11-28 | Medinol, Ltd. | Longitudinally flexible stent |
| US8920487B1 (en) | 2000-03-01 | 2014-12-30 | Medinol Ltd. | Longitudinally flexible stent |
| US6723119B2 (en) | 2000-03-01 | 2004-04-20 | Medinol Ltd. | Longitudinally flexible stent |
| EP1132060A2 (en) * | 2000-03-09 | 2001-09-12 | LPL Systems Inc. | Expandable stent |
| US7070614B1 (en) * | 2000-05-22 | 2006-07-04 | Malte Neuss | Radially expandable vessel support |
| US8034097B2 (en) * | 2000-05-22 | 2011-10-11 | Malte Neuss | Radially expandable vessel support |
| US6805704B1 (en) * | 2000-06-26 | 2004-10-19 | C. R. Bard, Inc. | Intraluminal stents |
| US6506211B1 (en) * | 2000-11-13 | 2003-01-14 | Scimed Life Systems, Inc. | Stent designs |
| US20050021123A1 (en) | 2001-04-30 | 2005-01-27 | Jurgen Dorn | Variable speed self-expanding stent delivery system and luer locking connector |
| US20030069629A1 (en) * | 2001-06-01 | 2003-04-10 | Jadhav Balkrishna S. | Bioresorbable medical devices |
| US20020188342A1 (en) * | 2001-06-01 | 2002-12-12 | Rykhus Robert L. | Short-term bioresorbable stents |
| US7547321B2 (en) * | 2001-07-26 | 2009-06-16 | Alveolus Inc. | Removable stent and method of using the same |
| ES2251609T3 (en) * | 2001-08-08 | 2006-05-01 | Arno Bucker | COMPATIBLE METALLIC ENDOPROTESIS WITH MAGNETIC RESONANCE. |
| US20030045923A1 (en) | 2001-08-31 | 2003-03-06 | Mehran Bashiri | Hybrid balloon expandable/self expanding stent |
| EP1293177B1 (en) * | 2001-09-18 | 2005-03-02 | Abbott Laboratories Vascular Enterprises Limited | Stent |
| US7537607B2 (en) | 2001-12-21 | 2009-05-26 | Boston Scientific Scimed, Inc. | Stent geometry for improved flexibility |
| DE10228529A1 (en) * | 2002-06-26 | 2004-01-22 | Admedes Schuessler Gmbh | stent |
| US20040054398A1 (en) * | 2002-09-13 | 2004-03-18 | Cully Edward H. | Stent device with multiple helix construction |
| US7527644B2 (en) * | 2002-11-05 | 2009-05-05 | Alveolus Inc. | Stent with geometry determinated functionality and method of making the same |
| US7637942B2 (en) | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
| US7959671B2 (en) | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
| US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
| DE10253633B4 (en) * | 2002-11-13 | 2011-08-11 | BIOTRONIK GmbH & Co. KG, 12359 | supporting structure |
| DE10328882B4 (en) * | 2003-06-26 | 2010-06-02 | Admedes Schuessler Gmbh | Use of a flexible shaft as a hose-like insertion device |
| US9155639B2 (en) | 2009-04-22 | 2015-10-13 | Medinol Ltd. | Helical hybrid stent |
| US9039755B2 (en) | 2003-06-27 | 2015-05-26 | Medinol Ltd. | Helical hybrid stent |
| WO2006024490A2 (en) | 2004-08-30 | 2006-03-09 | Interstitial Therapeutics | Methods and compositions for the treatment of cell proliferation |
| US20060079954A1 (en) * | 2004-10-08 | 2006-04-13 | Robert Burgermeister | Geometry and material for high strength, high flexibility, controlled recoil stent |
| US20060155367A1 (en) * | 2005-01-07 | 2006-07-13 | Hines Richard A | Micro-pleated stent assembly |
| US8317855B2 (en) * | 2005-05-26 | 2012-11-27 | Boston Scientific Scimed, Inc. | Crimpable and expandable side branch cell |
| US20090062909A1 (en) | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
| US8298565B2 (en) | 2005-07-15 | 2012-10-30 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
| DE102005037863B4 (en) | 2005-08-10 | 2018-10-18 | Carlo Civelli | Tubular supporting prosthesis with laterally overlapping curvature arches |
| ATE526911T1 (en) | 2005-08-17 | 2011-10-15 | Bard Inc C R | VARIABLE SPEED STENT DELIVERY SYSTEM |
| US20070112418A1 (en) * | 2005-11-14 | 2007-05-17 | Boston Scientific Scimed, Inc. | Stent with spiral side-branch support designs |
| EP1971299B1 (en) | 2006-01-13 | 2014-07-16 | C.R. Bard, Inc. | Stent delivery system |
| US11026822B2 (en) | 2006-01-13 | 2021-06-08 | C. R. Bard, Inc. | Stent delivery system |
| ES2540059T3 (en) | 2006-04-26 | 2015-07-08 | Micell Technologies, Inc. | Coatings containing multiple drugs |
| GB0615658D0 (en) | 2006-08-07 | 2006-09-13 | Angiomed Ag | Hand-held actuator device |
| US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
| US9737642B2 (en) | 2007-01-08 | 2017-08-22 | Micell Technologies, Inc. | Stents having biodegradable layers |
| US8128679B2 (en) * | 2007-05-23 | 2012-03-06 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with torque-absorbing connectors |
| US8016874B2 (en) | 2007-05-23 | 2011-09-13 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with elevated scaffolding properties |
| GB0713497D0 (en) | 2007-07-11 | 2007-08-22 | Angiomed Ag | Device for catheter sheath retraction |
| US7850726B2 (en) * | 2007-12-20 | 2010-12-14 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having struts linked by foot extensions |
| US8337544B2 (en) | 2007-12-20 | 2012-12-25 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having flexible connectors |
| US8920488B2 (en) | 2007-12-20 | 2014-12-30 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having a stable architecture |
| SG192524A1 (en) | 2008-04-17 | 2013-08-30 | Micell Technologies Inc | Stents having bioabsorbable layers |
| US8932340B2 (en) | 2008-05-29 | 2015-01-13 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
| WO2010009335A1 (en) | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
| US9510856B2 (en) | 2008-07-17 | 2016-12-06 | Micell Technologies, Inc. | Drug delivery medical device |
| US8128678B2 (en) * | 2008-09-02 | 2012-03-06 | Cook Medical Technologies Llc | Stent having less invasive ends and improved radial force |
| US9981072B2 (en) | 2009-04-01 | 2018-05-29 | Micell Technologies, Inc. | Coated stents |
| CA2759015C (en) | 2009-04-17 | 2017-06-20 | James B. Mcclain | Stents having controlled elution |
| EP2444033B1 (en) * | 2009-09-16 | 2015-01-28 | Terumo Kabushiki Kaisha | Stent for placement in living body, and stent delivery system |
| WO2011097103A1 (en) | 2010-02-02 | 2011-08-11 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
| EP2560576B1 (en) | 2010-04-22 | 2018-07-18 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
| CA2805631C (en) | 2010-07-16 | 2018-07-31 | Micell Technologies, Inc. | Drug delivery medical device |
| JP5942066B2 (en) * | 2010-09-15 | 2016-06-29 | 株式会社ネクスト２１ | Three-dimensional formable lattice structure |
| GB201017834D0 (en) | 2010-10-21 | 2010-12-01 | Angiomed Ag | System to deliver a bodily implant |
| EP4015022A1 (en) | 2010-12-06 | 2022-06-22 | AktiVax, Inc. | Aseptic cartridge |
| EP2658484A1 (en) | 2010-12-30 | 2013-11-06 | Boston Scientific Scimed, Inc. | Multi stage opening stent designs |
| WO2012119037A1 (en) | 2011-03-03 | 2012-09-07 | Boston Scientific Scimed, Inc. | Stent with reduced profile |
| CN103391757B (en) | 2011-03-03 | 2016-01-20 | 波士顿科学国际有限公司 | Low strain dynamic high strength support |
| WO2013012689A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
| US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
| CN106667630B (en) | 2012-05-14 | 2019-03-29 | C·R·巴德公司 | Can even inflation bracket |
| USD723165S1 (en) | 2013-03-12 | 2015-02-24 | C. R. Bard, Inc. | Stent |
| WO2014165264A1 (en) | 2013-03-12 | 2014-10-09 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
| EP2996629B1 (en) | 2013-05-15 | 2021-09-22 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
| US9549590B2 (en) * | 2013-09-18 | 2017-01-24 | Nike, Inc. | Auxetic structures and footwear with soles having auxetic structures |
| WO2016197351A1 (en) | 2015-06-11 | 2016-12-15 | Beijing Advanced Medical Technologies, Inc. | A close-cell structured stent, a preparation method and use thereof |
| US11154410B2 (en) * | 2018-06-29 | 2021-10-26 | Monarch Biosciences, Inc. | Spiral-based thin-film mesh systems and related methods |
| US11648115B2 (en) * | 2018-10-03 | 2023-05-16 | Edwards Lifesciences Corporation | Expandable introducer sheath |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US380831A (en) * | 1888-04-10 | Cash register and indicator | ||
| US390957A (en) * | 1888-10-09 | Tubes | ||
| US359802A (en) * | 1887-03-22 | Eugene o | ||
| US4950227A (en) * | 1988-11-07 | 1990-08-21 | Boston Scientific Corporation | Stent delivery system |
| USD390957S (en) | 1992-03-09 | 1998-02-17 | Cook Incorporated | Implantable intravascular stent |
| USD359802S (en) | 1991-06-28 | 1995-06-27 | Cook Incorporated | Vascular stent |
| USD380831S (en) | 1992-08-06 | 1997-07-08 | William Cook Europe A/S | Implantable self-expanding stent |
| US5524396A (en) | 1993-06-10 | 1996-06-11 | Lalvani; Haresh | Space structures with non-periodic subdivisions of polygonal faces |
| US5843120A (en) | 1994-03-17 | 1998-12-01 | Medinol Ltd. | Flexible-expandable stent |
| US5733303A (en) * | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
| CA2163824C (en) * | 1994-11-28 | 2000-06-20 | Richard J. Saunders | Method and apparatus for direct laser cutting of metal stents |
| US5591197A (en) | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
| WO1996033538A1 (en) * | 1995-04-17 | 1996-10-24 | Coherent, Inc. | High repetition rate erbium: yag laser for tissue ablation |
| US6176872B1 (en) | 1995-08-15 | 2001-01-23 | Ethicon, Inc. | Radial strength stent |
| DK171865B1 (en) | 1995-09-11 | 1997-07-21 | Cook William Europ | Expandable endovascular stent |
| JPH0998102A (en) | 1995-09-29 | 1997-04-08 | Sanyo Electric Co Ltd | Radio receiver |
| US5776161A (en) * | 1995-10-16 | 1998-07-07 | Instent, Inc. | Medical stents, apparatus and method for making same |
| WO1997025937A1 (en) | 1996-01-18 | 1997-07-24 | Jang G David | Programmable variably flexible modular stents |
| US5895406A (en) | 1996-01-26 | 1999-04-20 | Cordis Corporation | Axially flexible stent |
| US5695516A (en) * | 1996-02-21 | 1997-12-09 | Iso Stent, Inc. | Longitudinally elongating balloon expandable stent |
| CA2248718A1 (en) | 1996-03-05 | 1997-09-12 | Divysio Solutions Ulc. | Expandable stent and method for delivery of same |
| CA2192520A1 (en) | 1996-03-05 | 1997-09-05 | Ian M. Penn | Expandable stent and method for delivery of same |
| US5707387A (en) * | 1996-03-25 | 1998-01-13 | Wijay; Bandula | Flexible stent |
| US5833699A (en) * | 1996-04-10 | 1998-11-10 | Chuter; Timothy A. M. | Extending ribbon stent |
| CA2252596C (en) | 1996-04-26 | 2006-06-13 | G. David Jang | Intravascular stent |
| US6241760B1 (en) | 1996-04-26 | 2001-06-05 | G. David Jang | Intravascular stent |
| US5669932A (en) | 1996-05-29 | 1997-09-23 | Isostent, Inc. | Means for accurately positioning an expandable stent |
| US5697971A (en) * | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
| DE19633901A1 (en) | 1996-08-22 | 1998-02-26 | Thomas Prof Dr Med Ischinger | Vascular support in the form of a tube section-like support structure |
| US5776183A (en) | 1996-08-23 | 1998-07-07 | Kanesaka; Nozomu | Expandable stent |
| US5980530A (en) * | 1996-08-23 | 1999-11-09 | Scimed Life Systems Inc | Stent delivery system |
| US5807404A (en) | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
| WO1998018405A1 (en) | 1996-10-28 | 1998-05-07 | Biotronik Mess- Und Therapiegeräte Gmbh & Co. | Expandable interluminal device |
| WO1998018406A1 (en) * | 1996-10-28 | 1998-05-07 | Biotronik Mess- Und Therapiegeräte Gmbh & Co. | Stent |
| JP3798090B2 (en) | 1996-12-06 | 2006-07-19 | 株式会社パイオラックス | Stent |
| US6206911B1 (en) * | 1996-12-19 | 2001-03-27 | Simcha Milo | Stent combination |
| US5925061A (en) * | 1997-01-13 | 1999-07-20 | Gore Enterprise Holdings, Inc. | Low profile vascular stent |
| CA2214627A1 (en) | 1997-03-05 | 1998-09-05 | Divysio Solutions Ulc | Expandable stent |
| AU6464298A (en) | 1997-03-13 | 1998-09-29 | United States Surgical Corporation | Flexible tissue supporting device |
| US5810872A (en) * | 1997-03-14 | 1998-09-22 | Kanesaka; Nozomu | Flexible stent |
| US5824053A (en) * | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Helical mesh endoprosthesis and methods of use |
| US5718713A (en) | 1997-04-10 | 1998-02-17 | Global Therapeutics, Inc. | Surgical stent having a streamlined contour |
| AU7259298A (en) | 1997-04-25 | 1998-11-24 | G. David Jang | Intravascular stent |
| US6033433A (en) * | 1997-04-25 | 2000-03-07 | Scimed Life Systems, Inc. | Stent configurations including spirals |
| IT1292295B1 (en) * | 1997-04-29 | 1999-01-29 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT |
| DE29708689U1 (en) | 1997-05-15 | 1997-07-17 | Jomed Implantate Gmbh | Coronary stent |
| ATE255859T1 (en) | 1997-07-08 | 2003-12-15 | Evysio Medical Devices Ulc | EXPANDABLE STENT |
| US6231598B1 (en) * | 1997-09-24 | 2001-05-15 | Med Institute, Inc. | Radially expandable stent |
| US6013091A (en) | 1997-10-09 | 2000-01-11 | Scimed Life Systems, Inc. | Stent configurations |
| US6309414B1 (en) * | 1997-11-04 | 2001-10-30 | Sorin Biomedica Cardio S.P.A. | Angioplasty stents |
| US5935162A (en) | 1998-03-16 | 1999-08-10 | Medtronic, Inc. | Wire-tubular hybrid stent |
| US6558415B2 (en) * | 1998-03-27 | 2003-05-06 | Intratherapeutics, Inc. | Stent |
| US6461380B1 (en) * | 1998-07-28 | 2002-10-08 | Advanced Cardiovascular Systems, Inc. | Stent configuration |
| US6355059B1 (en) * | 1998-12-03 | 2002-03-12 | Medinol, Ltd. | Serpentine coiled ladder stent |
-
1999
- 1999-03-03 DE DE69931472T patent/DE69931472T2/en not_active Expired - Lifetime
- 1999-03-03 WO PCT/US1999/004686 patent/WO1999044543A1/en active IP Right Grant
- 1999-03-03 EP EP99909787A patent/EP1059896B1/en not_active Expired - Lifetime
- 1999-03-03 US US09/261,687 patent/US6395020B1/en not_active Expired - Lifetime
- 1999-03-03 DE DE69942515T patent/DE69942515D1/en not_active Expired - Lifetime
- 1999-03-03 AT AT05023103T patent/ATE471132T1/en not_active IP Right Cessation
- 1999-03-03 AT AT99909787T patent/ATE326919T1/en not_active IP Right Cessation
- 1999-03-03 EP EP05023103A patent/EP1656907B1/en not_active Expired - Lifetime
- 1999-03-03 JP JP2000534151A patent/JP4351388B2/en not_active Expired - Fee Related
- 1999-03-03 CA CA002322134A patent/CA2322134C/en not_active Expired - Fee Related
- 1999-05-07 US US09/307,580 patent/US6231599B1/en not_active Expired - Lifetime
-
2002
- 2002-04-23 US US10/131,772 patent/US7655032B2/en not_active Expired - Fee Related
-
2010
- 2010-02-02 US US12/698,413 patent/US20100131047A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE326919T1 (en) | 2006-06-15 |
| DE69942515D1 (en) | 2010-07-29 |
| EP1059896A1 (en) | 2000-12-20 |
| WO1999044543A1 (en) | 1999-09-10 |
| EP1656907B1 (en) | 2010-06-16 |
| US7655032B2 (en) | 2010-02-02 |
| EP1059896B1 (en) | 2006-05-24 |
| ATE471132T1 (en) | 2010-07-15 |
| US6395020B1 (en) | 2002-05-28 |
| US6231599B1 (en) | 2001-05-15 |
| US20020143391A1 (en) | 2002-10-03 |
| US20100131047A1 (en) | 2010-05-27 |
| JP4351388B2 (en) | 2009-10-28 |
| EP1656907A1 (en) | 2006-05-17 |
| JP2002505152A (en) | 2002-02-19 |
| CA2322134A1 (en) | 1999-09-10 |
| DE69931472D1 (en) | 2006-06-29 |
| DE69931472T2 (en) | 2006-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2322134C (en) | Improved stent cell configurations | |
| CA2303344C (en) | Improved stent configurations | |
| US7988718B2 (en) | Stent configurations | |
| EP2311412B2 (en) | Stent having helical elements | |
| US8303645B2 (en) | Methods and apparatus for a stent having an expandable web structure | |
| EP1399092B1 (en) | Stent designs | |
| EP1567088B1 (en) | Stent with improved flexibility | |
| US6821292B2 (en) | Crimpable intraluminal endoprosthesis having helical elements | |
| CA2401918C (en) | Self articulating stent | |
| AU712001B2 (en) | An expandable endovascular stent | |
| US8343208B2 (en) | Stent having an expandable web structure | |
| US6331189B1 (en) | Flexible medical stent | |
| GB2396112A (en) | Longitudinally flexible stent | |
| EP1357858B1 (en) | Crimpable intraluminal endoprosthesis having helical elements | |
| US8323331B2 (en) | Radially expansible stent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |